Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era

被引:0
|
作者
Choi, Won Jun [1 ]
Lee, Jinhong [2 ]
Choi, Kowoon [2 ]
Kim, Dong Mi [2 ]
Han, Nayoung [3 ]
Choi, Jin-Ho [4 ]
Jung, Jongheon [5 ]
Lee, Hyewon [5 ]
Choi, Jun Yong [6 ]
Choi, Young Ju [7 ]
Eom, Hyeon-Seok [5 ]
Chun, June Young [7 ]
Lee, Eunyoung [5 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul, South Korea
[2] Natl Canc Ctr, Infect Control Unit, Goyang, South Korea
[3] Natl Canc Ctr, Natl Canc Ctr Hosp, Dept Pathol, Goyang, South Korea
[4] Natl Canc Ctr, Res Inst & Hosp, Dept Thorac Surg, Goyang, South Korea
[5] Natl Canc Ctr, Dept Hematol Oncol, Ctr Hematol Malignancy, Goyang, South Korea
[6] Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea
[7] Natl Canc Ctr, Dept Internal Med, Div Infect Dis, Goyang, South Korea
关键词
HSCT outcomes in patients with COVID-19; HSCT; COVID-19; CLINICAL CHARACTERISTICS; RECIPIENTS; COVID-19;
D O I
10.1016/j.ijid.2024.107207
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Here, we present the outcomes of four patients with COVID-19 who underwent hematopoietic stem cell transplantation (HSCT) at the National Cancer Center in South Korea. Despite concerns about the unfavorable course of COVID-19 in HSCT recipients, none of our patients experienced severe COVID-19. Moreover, extended viral shedding in case 1, lasting over 100 days, was resolved after successful engraftment. Contracting the virus when the host could not mount enough of an immune reaction might result in a paradoxically favorable course. Vaccination, monoclonal antibodies, and antiviral agent usage against COVID-19 might also be effective. We suggest, if necessary, HSCT should not be deferred in COVID-19 patients. (c) 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Autologous hematopoietic stem cell transplantation with concomitant SARS-CoV-2 infection
    Knaus, Hanna A.
    Rabitsch, W.
    Buchtele, N.
    Cserna, J.
    Wohlfarth, P.
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (05) : 1107 - 1110
  • [2] Autologous hematopoietic stem cell transplantation with concomitant SARS-CoV-2 infection
    Hanna A. Knaus
    W. Rabitsch
    N. Buchtele
    J. Cserna
    P. Wohlfarth
    [J]. Annals of Hematology, 2022, 101 : 1107 - 1110
  • [3] At-home hematopoietic stem cell transplantation during SARS-CoV-2 pandemic
    Ballestar, Nuria
    Gallego Miralles, Cristina
    Guell, Estel
    Ayora, Pilar
    Garcia Barriga, Gloria
    Hernando Vicioso, Adelina
    Villa Rodriguez, Laura
    Segura Lerida, Susana
    Carreras Figuerola, Maria
    Martinez Roca, Alexandra Patricia
    Lourdes Corominas, Mo
    Domenech, Ariadna
    Rovira, Montserrat
    Valverde, Montserrat
    Fernandez Aviles, Francesc
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 348 - 349
  • [4] SARS-CoV-2 infection in autologous stem cell transplantation
    Wiltshire, Kaitlyn
    Kalff, Anna
    Morrissey, Catherine O.
    Griffin, David
    Patil, Sushrut
    Spring, Stephanie
    Spencer, Andrew
    Kliman, David
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 (08) : 1352 - 1353
  • [5] Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with a Donor and Recipient with SARS-CoV-2 Infection
    Ali, Gadallah
    Altareb, Majed
    Chaudhri, Naeem
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S325 - S326
  • [6] Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
    Chimon, Alice
    Ferriere, Elsa
    Lammouchi, Mohamed Ali
    Jouan, Narindra
    Michel, Pierre-Antoine
    Saloum, Kenda
    Morand-Joubert, Laurence
    Schnuriger, Aurelie
    Leruez-Ville, Marianne
    Fourgeaud, Jacques
    Dahmane, Djamal
    Bentaarit, Boutheina
    Guery, Bruno
    Fessi, Hafedh
    Kazdaghli, Hajer
    Sounni, Farah
    Fearon, Timothee
    Boudhabhay, Idris
    Pawlotsky, Jean-Michel
    El Karoui, Khalil
    Fourati, Slim
    Sakhi, Hamza
    [J]. CLINICAL KIDNEY JOURNAL, 2022, 15 (09) : 1785 - 1788
  • [7] Characteristics of febrile seizures with SARS-CoV-2 infection in the Omicron era
    Kim, Jee Min
    Park, Eu Gene
    Lee, Joo Young
    Kim, Young Hoon
    Kim, Yeji
    Kim, Hwan Soo
    Kim, Yejin
    Han, Ji Yoon
    Han, Seung Beom
    [J]. TRANSLATIONAL PEDIATRICS, 2023, 12 (05) : 807 - 815
  • [8] SARS-CoV-2 evolution in the Omicron era
    Cornelius Roemer
    Daniel J. Sheward
    Ryan Hisner
    Federico Gueli
    Hitoshi Sakaguchi
    Nicholas Frohberg
    Josette Schoenmakers
    Kenta Sato
    Áine O’Toole
    Andrew Rambaut
    Oliver G. Pybus
    Christopher Ruis
    Ben Murrell
    Thomas P. Peacock
    [J]. Nature Microbiology, 2023, 8 : 1952 - 1959
  • [9] SARS-CoV-2 evolution in the Omicron era
    Roemer, Cornelius
    Sheward, Daniel J.
    Hisner, Ryan
    Gueli, Federico
    Sakaguchi, Hitoshi
    Frohberg, Nicholas
    Schoenmakers, Josette
    Sato, Kenta
    O'Toole, Aine
    Rambaut, Andrew
    Pybus, Oliver G.
    Ruis, Christopher
    Murrell, Ben
    Peacock, Thomas P.
    [J]. NATURE MICROBIOLOGY, 2023, 8 (11) : 1952 - 1959
  • [10] Allogeneic hematopoietic stem cell transplantation in patients with prior infection caused by the sars-cov-2 (covid-19)
    Siniaev, A.
    Yanbukhtina, V.
    Kulagin, E.
    Popova, M.
    Rogacheva, Y.
    Vladovskaya, M.
    Bondarenko, S.
    Moiseev, I.
    Kulagin, A.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 283 - 283